Ifp Advisors, Inc Merus N.V. Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Merus N.V. stock. As of the latest transaction made, Ifp Advisors, Inc holds 2 shares of MRUS stock, worth $89. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$89

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 04, 2025	SELL	$41.45 - $54.5 $31,004 - $40,766	-748 Reduced 99.73%	2 $0
Q2 2024 Jul 30, 2024	BUY	$39.81 - $60.2 $29,857 - $45,150	750 New	750 $44,000

Others Institutions Holding MRUS

# of Institutions

201

Shares Held

57.2M

Call Options Held

111K

Put Options Held

85.7K

Rtw Investments, LP New York, NY

4.17M
Shares

$186 Million
2.86% of portfolio
Commodore Capital LP New York, NY

3.87M
Shares

$173 Million
16.32% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

2.97M
Shares

$133 Million
3.1% of portfolio
Samlyn Capital, LLC New York, NY

2.67M
Shares

$119 Million
1.81% of portfolio
Avoro Capital Advisors LLC New York, NY

2.13M
Shares

$94.8 Million
1.3% of portfolio

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.05B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account